Clincosm LogoSign in Get a demo

stage iv pancreatic cancer

Showing 26 - 50 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stage IV Pancreatic Cancer Trial (Nivolumab, Gemcitabine, Tegafur-Gimeracil-Oteracil)

Not yet recruiting
  • Stage IV Pancreatic Cancer
  • (no location specified)
May 4, 2020

Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Chicago (biological,

Completed
Has Results
  • Duct Cell Adenocarcinoma of the Pancreas
  • +3 more
  • ipilimumab
  • +2 more
  • Chicago, Illinois
    Northwestern University
Feb 24, 2020

Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Philadelphia (Oxaliplatin,

Completed
Has Results
  • Pancreatic Adenocarcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 15, 2020

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in

Terminated
Has Results
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Network
Oct 30, 2019

Stage IV Pancreatic Cancer Trial in Scottsdale, New Brunswick, Bethlehem (nab-paclitaxel, Cisplatin, gemcitabine)

Completed
Has Results
  • Stage IV Pancreatic Cancer
  • Scottsdale, Arizona
  • +2 more
May 5, 2019

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Apr 4, 2019

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Australia, Singapore, United

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Scottsdale, Arizona
  • +8 more
Mar 20, 2019

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • 6,8-bis(benzylthio)octanoic acid
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 26, 2018

Stage IV Pancreatic Cancer Trial in Russian Federation, United States (Gemcitabine, PEGPH20, Placebo)

Completed
Has Results
  • Stage IV Pancreatic Cancer
  • Fayetteville, Arkansas
  • +11 more
Oct 29, 2018

Stage IV Pancreatic Cancer Trial in Philadelphia (Ascorbic Acid)

Terminated
Has Results
  • Stage IV Pancreatic Cancer
  • Ascorbic Acid
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Jul 30, 2018

Extrahepatic Bile Duct Cancer, Nausea, Vomiting Trial in Winston-Salem (drug, procedure, other)

Completed
Has Results
  • Extrahepatic Bile Duct Cancer
  • +5 more
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jul 16, 2018

Recurrent Melanoma, Recurrent Pancreatic Cancer, Recurrent Renal Cell Cancer Trial in Winston-Salem (siRNA-transfected

Completed
  • Recurrent Melanoma
  • +11 more
  • siRNA-transfected peripheral blood mononuclear cells APN401
  • laboratory biomarker analysis
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Jul 2, 2018

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (drug,

Completed
Has Results
  • Pancreatic Acinar Cell Carcinoma
  • +3 more
  • Washington, District of Columbia
  • +5 more
Feb 8, 2018

Pancreatic Carcinoma Non-resectable, Stage IV Pancreatic Cancer Trial in Goodyear (Gemcitabine, nab-Paclitaxel)

Terminated
Has Results
  • Pancreatic Carcinoma Non-resectable
  • Stage IV Pancreatic Cancer
  • Goodyear, Arizona
    Western Regional Medical Center
Jan 11, 2018

Adenocarcinoma of Unknown Primary, Adult Cholangiocarcinoma, Gallbladder Carcinoma Trial in United States (Paclitaxel

Completed
  • Adenocarcinoma of Unknown Primary
  • +16 more
  • Paclitaxel Albumin-Stabilized Nanoparticle Formulation
  • +4 more
  • Chicago, Illinois
  • +7 more
Dec 8, 2017

Adenocarcinoma of the Pancreas, Pancreatic Cancer, Recurrent Pancreatic Cancer Trial in Toronto (eribulin mesylate)

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +5 more
  • eribulin mesylate
  • Toronto, Ontario, Canada
    University Health Network-Princess Margaret Hospital
Sep 19, 2017

Patient Derived Cancer Cell Lines in Identifying Molecular

Withdrawn
  • Pancreatic Ductal Adenocarcinoma
  • +6 more
  • Laboratory Biomarker Analysis
  • Cytology Specimen Collection Procedure
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Sep 5, 2017

Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer Trial in Ann Arbor (Gemcitabine Hydrochloride, Laboratory Biomarker

Completed
Has Results
  • Recurrent Pancreatic Carcinoma
  • Stage IV Pancreatic Cancer
  • Gemcitabine Hydrochloride
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Comprehensive Cancer Center
Aug 2, 2017

Duct Cell Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Rochester (drug,

Completed
  • Duct Cell Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Mar 21, 2017

Stage IV Pancreatic Cancer Trial in United States (OMP-59R5, Gemcitabine, Placebo)

Completed
  • Stage IV Pancreatic Cancer
  • Goodyear, Arizona
  • +25 more
Sep 16, 2016

Stage IV Pancreatic Cancer Trial in United States (Gemcitabine, nab-paclitaxel, FOLFIRINOX)

Completed
  • Stage IV Pancreatic Cancer
  • Scottsdale, Arizona
  • +4 more
Aug 17, 2016

Colon Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Trial in Buffalo (Fluorouracil, Irinotecan

Withdrawn
  • Colon Adenocarcinoma
  • +16 more
  • Buffalo, New York
    Roswell Park Cancer Institute
May 19, 2016

Pancreatic Acinar Cell Carcinoma, Pancreatic Ductal Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in United States (Akt

Completed
Has Results
  • Pancreatic Acinar Cell Carcinoma
  • +3 more
  • Akt Inhibitor MK2206
  • +3 more
  • Tucson, Arizona
  • +533 more
Feb 10, 2016

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Advanced Adult Primary Liver Cancer Trial in Nashville (cetuximab,

Completed
  • Adenocarcinoma of the Colon
  • +66 more
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
Sep 28, 2015

Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in United States (vismodegib,

Completed
Has Results
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Beverly Hills, California
  • +25 more
Jul 20, 2015